help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 67, No. 1 69-73
doi:10.1210/jcem-67-1-69
Copyright © 1988 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BARKAN, A. L.
Right arrow Articles by KELCH, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BARKAN, A. L.
Right arrow Articles by KELCH, R. P.

Plasma Insulin-Like Growth Factor-I/Somatomedin-C in Acromegaly: Correlation With the Degree of Growth Hormone Hypersecretion*

ARIEL L. BARKAN{dagger}, INESE Z. BEITINS and ROBERT P. KELCH

Departments of Internal Medicine and Pediatrics, Veterans Administration and University Hospitals, University of Michigan Medical Center Ann Arbor, Michigan 48105

Address all correspondence and requests for reprints to: Ariel L. Barkan, M.D., Endocrine Section, Veterans Administration Medical Center, 2215 Fuller Road, Ann Arbor, Michigan 48105.

We measured plasma insulin-like growth factor I/somatomedin-C (IGF-I/SmC) concentrations and mean 24-h GH secretion serially before and during therapy with the longacting somatostatin analog SMS 201–995 in 21 patients with acromegaly. When mean plasma GH was elevated above 12.0 ± 0.6 (±SE) µg/L. plasma IGF-I/SmC concentrations were uniformly high, but a decline of mean plasma GH below this value was accompanied by a linear decrease in IGF-I/SmC concentrations (r = 0.89; P < 0.001). Even mildly abnormal mean GH concentrations (>4.6 but <10 µg/L) were accompanied by high plasma IGF-I/SmC values. The log dose-response interrelation between mean 24-h plasma GH and IGF-I/SmC concentrations was linear (r = 0.86; P < 0.001). We conclude that 1) an excellent log dose-response correlation between mean 24-h plasma GH and IGF-I/SmC concentrations is present in patients with acromegaly; 2) normalization of plasma IGF-I/SmC occurs only in patients with mean daily GH output within the normal range; and 3) determination of plasma IGF-I/SmC is an accurate indicator of normalcy of GH secretion and should be used in the diagnosis of active acromegaly as well as in monitoring the progress of therapy.

* This work was supported by the V.A. Research Service and NIH Grants 1-R29-DK-38449-01 (to A.L.B.) and 5M01-RR-42 (to the Clinical Research Center).

{dagger} Recipient of the Career Development Research Associate Award from the V.A.

Received December 8, 1987.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M P Brugts, J G L M Luermans, E G W M Lentjes, N J van Trooyen-van Vrouwerff, F A L van der Horst, P H T. J Slee, S W J Lamberts, and J A M L Janssen
Heterophilic antibodies may be a cause of falsely low total IGF1 levels
Eur. J. Endocrinol., October 1, 2009; 161(4): 561 - 565.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Bianchi, A. Giustina, V. Cimino, R. Pola, F. Angelini, A. Pontecorvi, and L. De Marinis
Influence of Growth Hormone Receptor d3 and Full-Length Isoforms on Biochemical Treatment Outcomes in Acromegaly
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2015 - 2022.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Carmichael, V. S. Bonert, J. M. Mirocha, and S. Melmed
The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 523 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Segev, N. Berdugo-Boura, O. Porati, and A. Tarasiuk
Upper airway loading induces growth retardation and change in local chondrocyte IGF-I expression is reversed by stimulation of GH release in juvenile rats
J Appl Physiol, November 1, 2008; 105(5): 1602 - 1609.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. U. Freda, W. Shen, S. B. Heymsfield, C. M. Reyes-Vidal, E. B. Geer, J. N. Bruce, and D. Gallagher
Lower Visceral and Subcutaneous but Higher Intermuscular Adipose Tissue Depots in Patients with Growth Hormone and Insulin-Like Growth Factor I Excess Due to Acromegaly
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2334 - 2343.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Bajuk Studen and A. Barkan
Assessment of the Magnitude of Growth Hormone Hypersecretion in Active Acromegaly: Reliability of Different Sampling Models
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 491 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Resmini, P. Dadati, J.-L. Ravetti, G. Zona, R. Spaziante, A. Saveanu, P. Jaquet, M. D. Culler, F. Bianchi, A. Rebora, et al.
Rapid Pituitary Tumor Shrinkage with Dissociation between Antiproliferative and Antisecretory Effects of a Long-Acting Octreotide in an Acromegalic Patient
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1592 - 1599.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Tarasiuk and Y. Segev
Chronic upper airway resistive loading induces growth retardation via the GH/IGF-I axis in prepubescent rats
J Appl Physiol, March 1, 2007; 102(3): 913 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. U. Freda, L. Katznelson, A. J. van der Lely, C. M. Reyes, S. Zhao, and D. Rabinowitz
Long-Acting Somatostatin Analog Therapy of Acromegaly: A Meta-Analysis
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4465 - 4473.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Jehle, C. M. Reyes, R. E. Sundeen, and P. U. Freda
Alternate-Day Administration of Pegvisomant Maintains Normal Serum Insulin-Like Growth Factor-I Levels in Patients with Acromegaly
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1588 - 1593.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Mukherjee, J. P. Monson, P. J. Jonsson, P. J. Trainer, and S. M. Shalet
Seeking the Optimal Target Range for Insulin-Like Growth Factor I during the Treatment of Adult Growth Hormone Disorders
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5865 - 5870.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. R. Clemmons, K. Chihara, P. U. Freda, K. K. Y. Ho, A. Klibanski, S. Melmed, S. M. Shalet, C. J. Strasburger, P. J. Trainer, and M. O. Thorner
Optimizing Control of Acromegaly: Integrating a Growth Hormone Receptor Antagonist into the Treatment Algorithm
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4759 - 4767.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. J. Kopchick, C. Parkinson, E. C. Stevens, and P. J. Trainer
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
Endocr. Rev., October 1, 2002; 23(5): 623 - 646.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Parkinson, W. D. J. Ryder, and P. J. Trainer
The Relationship between Serum GH and Serum IGF-I in Acromegaly Is Gender-Specific
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5240 - 5244.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Marzullo, C. Di Somma, K. L. Pratt, J. Khosravi, A. Diamandis, G. Lombardi, A. Colao, and R. G. Rosenfeld
Usefulness of Different Biochemical Markers of the Insulin-Like Growth Factor (IGF) Family in Diagnosing Growth Hormone Excess and Deficiency in Adults
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3001 - 3008.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. A. Kaltsas, A. M. Isidori, D. Florakis, P. J. Trainer, C. Camacho-Hubner, F. Afshar, I. Sabin, J. P. Jenkins, S. L. Chew, J. P. Monson, et al.
Predictors of the Outcome of Surgical Treatment in Acromegaly and the Value of the Mean Growth Hormone Day Curve in Assessing Postoperative Disease Activity
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1645 - 1652.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. R. Biermasz, H. van Dulken, and F. Roelfsema
Long-Term Follow-Up Results of Postoperative Radiotherapy in 36 Patients with Acromegaly
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2476 - 2482.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. U. Freda, K. D. Post, J. S. Powell, and S. L. Wardlaw
Evaluation of Disease Status with Sensitive Measures of Growth Hormone Secretion in 60 Postoperative Patients with Acromegaly
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3808 - 3816.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Barkan, I. Halasz, K. J. Dornfeld, C. A. Jaffe, R. D. Friberg, W. F. Chandler, and H. M. Sandler
Pituitary Irradiation Is Ineffective in Normalizing Plasma Insulin-Like Growth Factor I in Patients with Acromegaly
J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3187 - 3191.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. L. Boguszewski, G. Johannsson, B.-A. Bengtsson, A. Johansson, B. Carlsson, and L. M. S. Carlsson
Circulating Non-22-Kilodalton Growth Hormone Isoforms in Acromegalic Men before and after Transsphenoidal Surgery
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1516 - 1521.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. J. H. Janssen, M. Frolich, and F. Roelfsema
A Low Starting Dose of Genotropin in Growth Hormone-Deficient Adults
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 129 - 135.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. S. Jaffe and H. N. Rosen
Normal Insulin-like Growth Factor-I in an Elderly Woman With Acromegaly and Medical Illness
Arch Intern Med, July 11, 1994; 154(13): 1533 - 1535.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
D. LeRoith, D. Clemmons, P. Nissley, and M. M. Rechler
Insulin-like Growth Factors in Health and Disease
Ann Intern Med, May 15, 1992; 116(10): 854 - 862.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. L. Vance and A. G. Harris
Long-term Treatment of 189 Acromegalic Patients With the Somatostatin Analog Octreotide: Results of the International Multicenter Acromegaly Study Group
Arch Intern Med, August 1, 1991; 151(8): 1573 - 1578.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
W. H. Daughaday
Octreotide Is Effective in Acromegaly But Often Results in Cholelithiasis
Ann Intern Med, February 1, 1990; 112(3): 159 - 160.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society